![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » KV PHARMACEUTICAL COMPANY REPORTS FISCAL 2006 RESULTS
KV PHARMACEUTICAL COMPANY REPORTS FISCAL 2006 RESULTS
June 14, 2006
KV Pharmaceutical Company, a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology distinguished branded and generic/non-branded prescription pharmaceutical products, today reported results for the fourth quarter and fiscal year ended March 31, 2006, marking its 11th consecutive year of record revenues. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus.story&STORY=/www/story/06-14-2006/0004380484&EDATE=WED%2BJun%2B14%2B2006,%2B09:22%2BAM)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct